murad atmaca
murad atmaca
firat.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
M Kuloglu, B Ustundag, M Atmaca, H Canatan, AE Tezcan, N Cinkilinc
Cell biochemistry and function 20 (2), 171-175, 2002
3762002
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics
M Atmaca, M Kuloglu, E Tezcan, B Ustundag
Journal of Clinical Psychiatry 64 (5), 598-604, 2003
2812003
Quetiapine augmentation in patients with treatment resistant obsessive–compulsive disorder: a single-blind, placebo-controlled study
M Atmaca, M Kuloglu, E Tezcan, O Gecici
International clinical psychopharmacology 17 (3), 115-119, 2002
2212002
Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder
M Atmaca, S Kumru, E Tezcan
Human Psychopharmacology: Clinical and experimental 18 (3), 191-195, 2003
2182003
Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder
M Kuloglu, M Atmaca, E Tezcan, Ö Gecici, H Tunckol, B Ustundag
Neuropsychobiology 46 (1), 27-32, 2002
1962002
Volumetric MRI study of key brain regions implicated in obsessive–compulsive disorder
M Atmaca, H Yildirim, H Ozdemir, E Tezcan, AK Poyraz
Progress in neuro-psychopharmacology and Biological Psychiatry 31 (1), 46-52, 2007
1752007
Impulse control disorders and “behavioural addictions” in the ICD-11
JE Grant, M Atmaca, NA Fineberg, LF Fontenelle, H Matsunaga, ...
World Psychiatry 13 (2), 125, 2014
1642014
Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study
S Bulut, MS Berilgen, A Baran, A Tekatas, M Atmaca, B Mungen
Clinical neurology and neurosurgery 107 (1), 44-48, 2004
1612004
The classification of obsessive–compulsive and related disorders in the ICD-11
DJ Stein, CS Kogan, M Atmaca, NA Fineberg, LF Fontenelle, JE Grant, ...
Journal of affective disorders 190, 663-674, 2016
1592016
Antioxidant enzyme and malondialdehyde levels in patients with panic disorder
M Kuloglu, M Atmaca, E Tezcan, B Ustundag, S Bulut
Neuropsychobiology 46 (4), 186-189, 2002
1532002
Serum leptin and cholesterol values in suicide attempters
M Atmaca, M Kuloglu, E Tezcan, B Ustundag, O Gecici, B Firidin
Neuropsychobiology 45 (3), 124-127, 2002
1272002
The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study
M Atmaca, M Kuloglu, E Tezcan, A Semercioz
International journal of impotence research 14 (6), 502-505, 2002
1162002
Serum leptin and cholesterol levels in patients with bipolar disorder
M Atmaca, M Kuloglu, E Tezcan, B Ustundag, Y Bayik
Neuropsychobiology 46 (4), 176-179, 2002
1142002
Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts
M Atmaca, M Kuloglu, E Tezcan, B Ustundag
Acta Psychiatrica Scandinavica 108 (3), 208-214, 2003
1022003
Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment
M Atmaca, E Tezcan, M Kuloglu, B Ustundag, H Tunckol
European Archives of Psychiatry and Clinical Neuroscience 254 (4), 231-235, 2004
992004
Volumetric MRI assessment of brain regions in patients with refractory obsessive–compulsive disorder
M Atmaca, H Yildirimb, H Ozdemirb, A Aydinb, E Tezcana, S Ozlera
Progress in Neuro-Psychopharmacology and Biological Psychiatry 30 (6), 1051-1057, 2006
962006
Hippocampus and amygdalar volumes in patients with refractory obsessive–compulsive disorder
M Atmaca, H Yildirim, H Ozdemir, S Ozler, B Kara, Z Ozler, E Kanmaz, ...
Progress in neuro-psychopharmacology and Biological Psychiatry 32 (5), 1283-1286, 2008
922008
A case of problematic internet use successfully treated with an SSRI-antipsychotic combination.
M Atmaca
Progress in neuro-psychopharmacology & biological psychiatry 31 (4), 961-962, 2007
912007
High serum leptin levels in depressive disorders with atypical features
O Gecici, M Kuloglu, M Atmaca, AE Tezcan, H Tunckol, HM EMüL, ...
Psychiatry and clinical neurosciences 59 (6), 736-738, 2005
892005
Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol
M Atmaca, M Kuloglu, E Tezcan, O Gecici, B Ustundag
Schizophrenia Research 60 (1), 99-100, 2003
872003
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20